12 recruiting. 12 Phase 2, 7 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 12 | Recruiting 12 |
| Phase 1 | 7 | Recruiting 7 |
Follow Healthy: new trials by email Literature Review of Healthy trials Research Report on Healthy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Psilocybin Efficacy With or Without Pimavanserin Pretreatment Psilocybin, Pimavanserin, Inactive Placebo - Mood (Psychological Function), Well Being | Phase 1 / Phase 2 | Recruiting | Johns Hopkins University | 20 | 2026-10-29 | 2026-11-02 |
| Naturally Produced Cannabinoids for Neuroprotection From Concussion Broad spectrum cannabinoid formulation, Placebo gel capsule - Healthy | Phase 2 | Recruiting | University of Regina | 60 | 2026-06-01 | 2026-07-21 |
| Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity Fisetin, Placebo - Multimorbidity, Healthy | Phase 1 / Phase 2 | Recruiting | Ove Andersen | 60 | 2026-03-24 | 2026-05-19 |
| Resistance Training and Rapamycin to Enhance Bone Formation in Postmenopausal Women Everolimus, Placebo, Resistance training - Healthy, Osteopenia | Phase 2 | Recruiting | Odense University Hospital | 148 | 2025-10-20 | 2026-04-06 |
| Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster in Healthy Adults LVT-001, Cormirnaty - Healthy | Phase 1 / Phase 2 | Recruiting | ANRS, Emerging Infectious Diseases | 238 | 2025-05-09 | 2025-12-18 |
| Effects of an Antioxidant Supplement on Blood Vessel Health MitoQ, Placebo, MitoTempo - Healthy | Phase 2 | Recruiting | University of Georgia | 60 | 2024-07-01 | 2024-12-09 |
| Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder. Fecal microbiota transplantation - Autism Spectrum Disorder, Gastrointestinal Diseases | Phase 1 / Phase 2 | Recruiting | Chang Gung Memorial Hospital | 60 | 2024-03-06 | 2026-03-20 |
| SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy SV2A PET, TSPO PET - HIV Associated Neurocognitive Disorder, HIV Dementia | Phase 1 / Phase 2 | Recruiting | Yale University | 70 | 2023-05-17 | 2026-10-14 |
| Viral Mucosal Reprogramming Research Grade RG-RV - Asthma, Allergic Rhinitis | Phase 2 | Recruiting | The University of Texas Medical Branch, Galveston | 75 | 2023-04-27 | 2025-01-28 |
| Effectiveness of Aquamin® in Mitigating Halitosis Aquamin - Healthy, Halitosis | Phase 2 | Recruiting | University of Michigan | 25 | 2022-08-15 | 2026-08-28 |
| Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought Psilocybin, Placebo - Healthy | Phase 1 / Phase 2 | Recruiting | Johns Hopkins University | 30 | 2022-03-03 | 2026-07-23 |
| Comparison of the Short-Term Effect of Dietary Carbohydrate Restriction Versus Exogenous Ketone Supplementation on Myocardial Glucose Suppression and Timing to Achieve a State of Ketosis Using FDG PET/CT Serial Imaging FDG, Ketone Drink, Ketogenetic Diet - Healthy | Phase 1 / Phase 2 | Recruiting | University of Pennsylvania | 20 | 2020-01-05 | 2020-07-16 |
AIDS Dementia Complex (1) · Acquired Immunodeficiency Syndrome (1) · Asthma (1) · Autism Spectrum Disorder (1) · Bone Diseases, Metabolic (1) · Brain Concussion (1) · COVID-19 (1) · Cardiovascular Diseases (1) · Color Vision Defects (1) · Gastrointestinal Diseases (1) · Halitosis (1) · Hypersensitivity (1) · Hypertension (1) · Inflammation (1) · Marijuana Abuse (1)
Infections (3) · Mental Disorders (3) · Brain Diseases (2) · Central Nervous System Diseases (2) · Immune System Diseases (2) · Lung Diseases (2) · Nervous System Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · RNA Virus Infections (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Signs and Symptoms (2) · Virus Diseases (2) · Blood-Borne Infections (1) · Bone Diseases (1)
Psilocybin (2) · (methyl-(11)C)N-acetyl-N-(2-methoxybenzyl)-2-phenoxy-5-pyridinamine (1) · 1-((3-(methylpyridin-4-yl)methyl)-4-(3,4,5-trifluorophenyl)pyrrolidin-2-one (1) · Aquamin (1) · Everolimus (1) · Fecal Microbiota Transplantation (1) · MitoTEMPO (1) · NG-Nitroarginine Methyl Ester (1) · Resistance Training (1) · fisetin (1) · mitoquinone (1) · pimavanserin (1) · tempol (1)
Johns Hopkins University (2) · ANRS, Emerging Infectious Diseases (1) · Chang Gung Memorial Hospital (1) · Odense University Hospital (1) · Ove Andersen (1) · The University of Texas Medical Branch, Galveston (1) · University of Georgia (1) · University of Michigan (1) · University of Pennsylvania (1) · University of Regina (1) · Yale University (1)
United States (7) · Denmark (2) · Canada (1) · France (1) · Taiwan (1)
David B. Yaden, PhD (1) · Frederick S Barrett, PhD (1) · Iwonka Eagle (1) · Jan O Nehlin (1) · Juliette Tavenier (1) · Line Jee Hartmann Rasmussen (1) · Morten B Houlind (1) · Moustapha Kassem, MD (1) · Muhammad N Aslam (1) · Ove Andersen (1) · Serena Spudich, MD (1) · Wei-Chih Chin (1) · William J. Calhoun, MD (1)
2023 (1), R01MH125396 (1)